Menu
Back to Journals » OncoTargets and Therapy » Volume 11
A small compound spindlactone A sensitizes human endometrial cancer cells to TRAIL-induced apoptosis via the inhibition of NAD(P)H dehydrogenase quinone 1 [Corrigendum]
Received 4 December 2018
Accepted for publication 4 December 2018
Published 10 December 2018 Volume 2018:11 Pages 8943—8944
Zhao XZ, Wu XH. Onco Targets Ther. 2018;11:3609–3617.
On page 3609, affiliation 2 should read as follows:
2Department of Gynecology and Obstetrics, Hebei Medical University, Hebei 050017, People’s Republic of China
On page 3609, the correspondence details should read as follows:
Correspondence: Xiao-Hua Wu
Department of Gynecology and Obstetrics, Hebei Medical University, No 361 East Zhongshan Road, Shijiazhuang, Hebei, 050017, People’s Republic of China
Tel/fax +86 311 8702 3626
Email [email protected]
Read the original article
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.